Publications

Publications

  1. Golia Pernicka, JS, Gagniere, J, Chakraborty, J, Yamashita, R, Nardo, L, Creasy, JM et al.. Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluation. Abdom Radiol (NY). 2019; :. doi: 10.1007/s00261-019-02117-w. PubMed PMID:31250180 .
  2. Attiyeh, MA, Chakraborty, J, McIntyre, CA, Kappagantula, R, Chou, Y, Askan, G et al.. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2019; :. doi: 10.1007/s00261-019-02112-1. PubMed PMID:31243486 .
  3. McIntyre, CA, Pulvirenti, A, Lawrence, SA, Seier, K, Gonen, M, Balachandran, VP et al.. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas. 2019;48 (6):832-836. doi: 10.1097/MPA.0000000000001342. PubMed PMID:31210665 .
  4. Knapp, GC, Alatise, OI, Olasehinde, OO, Adeyeye, A, Ayandipo, OO, Weiser, MR et al.. Is Colorectal Cancer Screening Appropriate in Nigeria?. J Glob Oncol. 2019;5 :1-10. doi: 10.1200/JGO.19.00035. PubMed PMID:31170018 PubMed Central PMC6613663.
  5. Deng, L, Ismond, K, Liu, Z, Constable, J, Wang, H, Alatise, OI et al.. Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicentre Study. Cancer Epidemiol. Biomarkers Prev. 2019; :. doi: 10.1158/1055-9965.EPI-18-1291. PubMed PMID:31151939 .
  6. Wang, T, Drill, E, Vakiani, E, Pak, LM, Boerner, T, Askan, G et al.. Distinct histomorphological features are associated with IDH1 mutation in intrahepatic Cholangiocarcinoma. Hum. Pathol. 2019; :. doi: 10.1016/j.humpath.2019.05.002. PubMed PMID:31121195 .
  7. Doussot, A, Jarnagin, WR, Azoulay, D, Heyd, B. Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go. Hepatobiliary Surg Nutr. 2019;8 (2):161-163. doi: 10.21037/hbsn.2018.11.21. PubMed PMID:31098368 PubMed Central PMC6503243.
  8. Olasehinde, O, Arije, O, Wuraola, FO, Samson, M, Olajide, O, Alabi, T et al.. Life Without a Breast: Exploring the Experiences of Young Nigerian Women After Mastectomy for Breast Cancer. J Glob Oncol. 2019;5 :1-6. doi: 10.1200/JGO.18.00248. PubMed PMID:31095453 PubMed Central PMC6550027.
  9. Creasy, JM, Goldman, DA, Gonen, M, Dudeja, V, O'Reilly, EM, Abou-Alfa, GK et al.. Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. HPB (Oxford). 2019; :. doi: 10.1016/j.hpb.2019.03.370. PubMed PMID:31027875 .
  10. Narayan, RR, Kingham, TP. ASO Author Reflections: Perioperative Genomic Profiles and Prognosis of Peripheral and Perihepatic Circulating Tumor DNA in Patients with Colorectal Liver Metastases. Ann. Surg. Oncol. 2019; :. doi: 10.1245/s10434-019-07360-5. PubMed PMID:30989499 .
  11. Wang, T, Askan, G, Adsay, V, Allen, P, Jarnagin, WR, Memis, B et al.. Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas. Am. J. Surg. Pathol. 2019;43 (5):656-661. doi: 10.1097/PAS.0000000000001226. PubMed PMID:30986801 PubMed Central PMC6467507.
  12. Buisman, FE, Homs, MYV, Grünhagen, DJ, Filipe, WF, Bennink, RJ, Besselink, MGH et al.. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial. BMC Cancer. 2019;19 (1):327. doi: 10.1186/s12885-019-5515-6. PubMed PMID:30953467 PubMed Central PMC6451273.
  13. Cavnar, MJ, Seier, K, Curtin, C, Balachandran, VP, Coit, DG, Yoon, SS et al.. Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre and Post-imatinib Eras. Ann. Surg. 2019; :. doi: 10.1097/SLA.0000000000003277. PubMed PMID:30946076 .
  14. Ellis, RJ, Angelos, P, Jarnagin, WR, Kemeny, NE, Merkow, RP. Abrupt Discontinuation of the Codman Hepatic Artery Infusion Pump: Considerations in the Era of Precision Medicine. J. Am. Coll. Surg. 2019; :. doi: 10.1016/j.jamcollsurg.2019.03.002. PubMed PMID:30878584 .
  15. Gholami, S, Kemeny, NE, Boucher, TM, Gönen, M, Cercek, A, Kingham, TP et al.. Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. Ann. Surg. 2019; :. doi: 10.1097/SLA.0000000000003248. PubMed PMID:30817353 .
  16. Zheng, J, Chapman, WC, Turcotte, S, Koerkamp, BG, Lee, SY, Jarnagin, WR et al.. Response to the Comment on "Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in Aninternational Cohort". Ann. Surg. 2019;269 (3):e34-e35. doi: 10.1097/SLA.0000000000002871. PubMed PMID:30724808 .
  17. Narayan, RR, Goldman, DA, Gonen, M, Reichel, J, Huberman, KH, Raj, S et al.. Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer. Ann. Surg. Oncol. 2019;26 (6):1824-1832. doi: 10.1245/s10434-019-07201-5. PubMed PMID:30706231 PubMed Central PMC6511310.
  18. Corrias, G, Raeside, MC, Agostini, A, Huicochea-Castellanos, S, Aramburu-Nunez, D, Paudyal, R et al.. Pilot study of rapid MR pancreas screening for patients with BRCA mutation. Eur Radiol. 2019;29 (8):3976-3985. doi: 10.1007/s00330-018-5975-0. PubMed PMID:30689033 PubMed Central PMC6609466.
  19. Pak, LM, Gagnière, J, Allen, PJ, Balachandran, VP, D'Angelica, MI, DeMatteo, RP et al.. Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases. J. Gastrointest. Surg. 2019;23 (4):760-767. doi: 10.1007/s11605-019-04106-2. PubMed PMID:30680630 .
  20. Balachandran, VP, Beatty, GL, Dougan, SK. Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities. Gastroenterology. 2019;156 (7):2056-2072. doi: 10.1053/j.gastro.2018.12.038. PubMed PMID:30660727 PubMed Central PMC6486864.
Search PubMed